Effect of 1% Melatonin Gel Versus Calcium Hydroxide as an Intracanal Medicament on the Intensity of Postoperative Pain, Bacterial Load Reduction and Periapical MMP-9 Levels in Patients With Necrotic Pulp.
RCT
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
To compare the effect of 1% melatonin gel versus calcium hydroxide as intra canal medication in necrotic mandibular premolars on:
- Intensity of postoperative pain.
- Bacterial load reduction.
- Periapical (MMP-9) level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2026
CompletedStudy Start
First participant enrolled
March 22, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
March 27, 2026
March 1, 2026
1.7 years
March 8, 2026
March 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Intensity of postoperative pain
Intensity of postoperative pain will be measured using numerical rating scale (NRS) at 6, 12, 24 and 48- hours post-instrumentation and at 6, 12, 24 and 48 hours post-obturation
up to 48 hours
Secondary Outcomes (2)
Bacterial load reduction
intraoperative
Periapical MMP-9 level
intraoperative
Study Arms (2)
calcium hydroxide
ACTIVE COMPARATORCalcium Hydroxide (Metapaste. META BIOMED CO., LTD, Korea): It is a water-soluble, premixed
1% melatonin gel
EXPERIMENTAL1% melatonin gel: was prepared in the Drug Manufacture Unit, Faculty of Pharmacy, Cairo university
Interventions
1% melatonin gel: was prepared in the Drug Manufacture Unit, Faculty of Pharmacy, Cairo university
a water-soluble, premixed calcium hydroxide paste with barium sulfate, supplied in a 2.2g syringe
Eligibility Criteria
You may qualify if:
- Age between 18-50 years old.
- Males and females.
- Healthy patients categorized as I or II according to The American Society of Anesthesiologists. (ASA I or II), with no underlying allergies.
- Single-rooted mandibular premolar teeth, having single root canal: diagnosed clinically with pulp necrosis.
- Patients accepting to participate in the trial.
- Patients who can understand pain scale (Appendix I) and can sign the informed consent (Appendix II).
You may not qualify if:
- Medically compromised patients having significant systemic disorders (ASA III or IV).
- Pregnant females.
- If analgesics or antibiotics have been administrated by the patient during the past 24 hours preoperatively as it might alter their pain perception.
- Teeth with multiple canals.
- Teeth that show association with acute periapical abscess or swelling.
- Teeth with vital pulp.
- Non-restorable teeth or teeth that could not be adequately isolated with a rubber dam.
- Immature teeth.
- Teeth with greater than grade I mobility or pocket depth greater than 4 mm.
- Teeth showing radiographic evidence of external or internal root resorption, vertical root fracture, perforation or calcification.
- Patients with two or more adjacent teeth requiring endodontic treatment.
- Patients reporting bruxism, clenching or TMJ problems.
- Teeth with previous endodontic treatment.
- Inability to perceive the given instructions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
March 8, 2026
First Posted
March 27, 2026
Study Start
March 22, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
March 27, 2026
Record last verified: 2026-03